The contrast between the PhD and Postdoc office plants Academic Chatter™ #phdlife

Happy to share my first first co-author review! Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy frontiersin.org/article/10.338… thank you @velasquez_lab @PaulinaV_MD and @JTZoine St. Jude Graduate School of Biomedical Sciences #WomenInSTEM #CARTcells #AcademicTwitter

PhD candidate Elizabeth Wickman will present her work at ASGCT May 18. She will discuss a potential target for CAR T cells in the immunotherapy of pediatric brain and solid tumors. Learn more. ow.ly/Q6pO50J6OYV #ASGCT22

PhD student Matthew Bell will participate in the “CAR T cell Efficacy” session at ASGCT. May 17 he will discuss his work engineering a more effective CAR T cell immunotherapy for solid tumors. Learn more. ow.ly/Q6pO50J6OYV #ASGCT22

So excited to kick off the #ASGCT22 conference with the Pre-Meeting Immune Effector Cell Therapies Workshop! ASGCT @GiedreKrenciute

Great research, exciting talks, and my favorite post doc @JTZoine representing @velasquez_lab at #ASGCT22 for my first #inperson conference! #teamCART #Immunotherapy #genetherapy St. Jude Graduate School of Biomedical Sciences St. Jude Research ASGCT

Watch “Naturally Occurring CD7- T-cells Mark a Functional Effector and Persistent CAR T-cell Population,” presented by Dr. Jacquelyn Zoine Monday, May 16, at 4:30 pm ET in the CAR T-cells and Beyond session in Room 102 at #ASGCT22. ow.ly/qLpr50J8nio @JTZoine

Fascinating research Federico Rossari Luigi NALDINI utilizing #genetherapy to reprogram the harsh GBM TME, thus enhancing #CARTcell efficacy ASGCT #ASGCT22

Watch Dr. Jacquelyn Zoine’s talk, “Peptide-scFv Bispecific CAR T-cells Targeting Acute Myeloid Leukemia,” today at 5 pm ET in the CAR T-cells and Beyond session in Room 102 at #ASGCT22. ow.ly/4J3J50J8nkM @JTZoine

Day 1 at first #inperson conference #ASGCT2022 was a success! ASGCT St. Jude Research St. Jude Graduate School of Biomedical Sciences check out my poster on #wednesday #CARTcell #Immunotherapy #AcademicChatter #phdchat

Exciting new research coming out of the Luigi NALDINI! Great talk by Federico Rossari ASGCT #ASGCT2022

Thank you Nathan Schloemer Children's Wisconsin 🏥 Medical College of Wisconsin for a great talk at #ASGCT22 expanding my knowledge of NK cell biology and the advancements of NK cells for cancer therapy! #NKCells #ASGCTherapy

Zippity-receptor-doo-dah! Can’t wait for Matthew Bell’s first presentation and to ~switch~ it up with Brooke Prinzing’s new high-affinity receptor at the Enhancing CAR-T Cell Efficacy #ASGCT22 Room 102A/B at 3:45 St. Jude Graduate School of Biomedical Sciences St. Jude Research ASGCT

.Matthew Bell will present “Leucine Zipper-based Cytokine Receptors Augments CAR T-cell Immunotherapy for Solid Tumors” at 3:45 pm ET Tues, May 17, during the CAR T-cell Efficacy session in Room 102. ow.ly/ul9Q50J9iPF #ASGCT22

Join the CAR T-cell Efficacy session at #ASGCT22 to hear Brooke Prinzing present “High-affinity PD1-CD28 Chimeric Switch Receptors Enhance Costimulatory Signaling and Improve TCR and CAR T-cell Antitumor Activity” at 5 pm ET, May 17 in Room 102. ow.ly/RBBH50J9vSu

Starting off the morning of day 3 #ASGCT2022 right - by listening to groundbreaking research in Late-Breaking Abstracts II with coffee in hand Matthew Bell ASGCT

Pumped to support my fellow St. Jude Graduate School of Biomedical Sciences student’s Lizzie Wickman at the Cell-Based Cancer Immunotherapy II session Salon G at 3:45 and @itsalexbeckett at Poster 233 5:30-6:30 #teamCART #immunotherapy #ASGCT2022 St. Jude Research ASGCT

Lizzie Wickman did a fantastic job presenting her talk “Targeting the C Domain of Tenascin C with CAR T Cells for the Immunotherapy of Pediatric Brain and Solid Tumor” St. Jude Graduate School of Biomedical Sciences St. Jude Research #ASGCT22 ASGCT

Last day of #ASGCT22! Don’t forget to tune into Jorge’s talk “Dysfunctional Immune Synapses Restrain Anti DIPG Activity of CAR T Cells” in person or virtually at 11:30 EST room 206 St. Jude Research ASGCT #CARTcells #DIPG

The only known cure for sickle cell disease is bone marrow transplantation. In 1983, St. Jude doctors were the first to make that discovery. Join the next generation of investigators who will discover cures and advance research. ow.ly/FUfa50IPeER